Loncar Cancer Immunotherapy ETF (CNCR)
NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 13.95 |
| Open | 13.97 |
| Bid | 14.28 x 500 |
| Ask | 14.57 x 500 |
| Day's range | 13.94 - 14.43 |
| 52-week range | 9.22 - 17.96 |
| Volume | |
| Avg. volume | 37,931 |
| Net assets | 28.75M |
| NAV | 13.99 |
| PE ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD daily total return | 3.56% |
| Beta (5Y monthly) | 0.89 |
| Expense ratio (net) | 0.79% |
| Inception date | 2015-10-13 |
PR NewswireEXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATION
Exchange Traded Concepts, LLC, adviser to the Range Cancer Therapeutics ETF (CNCR) and the Loncar China BioPharma ETF (CHNA) is pleased to announce the completion of the reorganization of CHNA into CNCR following the close of business on October 20, 2023.
© 2024 Yahoo. All rights reserved.